Setting new standards in information exchange for the pharmaceutical and biotech industry
Conference Forum Speaker, Ken Getz quoted in WSJ on the Challenges of Patient Recruitment
April 12, 2016
Conference Forum Speaker, Ken Getz, Tufts CSDD quoted in the Wall Street Journal article on the challenges of patient recruitment and the longstanding issue of excessively expensive clinical trials.
From the WSJ:
Researchers conduct clinical trials to test new drugs and medical treatments, but the rate at which they are able to recruit and retain patients is at an all-time low.
Studies indicate that fewer than 10% of Americans participate in clinical trials, and only 3% to 5% of patients sign up for trials of new cancer therapies. Patients often aren’t aware that trials are an option, and their doctors may not suggest them.
Some patients mistrust the research process and fear being a guinea pig, but for patients who do want to volunteer, complicated protocols and eligibility requirements can be discouraging. About 40% of clinical trials don’t recruit enough patients to meet their goals.
“The challenges of identifying, recruiting and retaining volunteers for clinical trials drive up the direct and indirect costs of drug development and significantly delay the introduction of new medical interventions,” says Ken Getz, an associate professor at Tufts University School of Medicine’s Center for the Study of Drug Development and board chair of the nonprofit Center for Information & Study on Clinical Research Participation.
Read the rest of the article here: http://www.wsj.
com/articles/cl inical-trials-n eed-more-subjec ts-1460407076
Ken will be speaking at the upcoming Chef Medical Officer Summit East (May 11-12, 2016, Boston).